The in vitro lung model market was valued at US$ 185.80 million in 2018 and it is projected to reach US$ 701.81 million in 2027; it is expected to grow at a CAGR of 16.2% from 2019 to 2027.
In vitro models are very vital in medicine and biology research, as they provide essential information of cells in an organ. The organ on chip is a device which has cultured cells on the microfluidic chip. The chip mimics the bioactivities, mechanics and physiological behavior of the organ systems. Lung in vitro models help in understanding the processes like drug discovery, stem cell research, personalized medicine and others. The growth of the global in vitro lung model market is attributed to the significant growth in research funding and increasing adoption of 3D model systems for in vitro studies. However, dearth of skilled professionals is the major factor hindering the market growth.
The global in vitro lung model market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Global In Vitro Lung Model Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Adoption Of 3D Model Systems For In Vitro Studies to Drive Global In Vitro Lung Model Market Growth
Cell culture is a very valuable tool in cellular biology research. The use of cell lines for in-vitro studies in cellular biology research enables mimicking the in vivo environment, and there is homogeneity in data generated. In vitro studies permit a simpler, convenient, and detailed analysis for research. In vitro studies on model systems are reducing human trials, as well as replacing studies in whole animals. Furthermore, studies in animal models for lung diseases have led to the understanding of disease mechanisms and have also identified potential novel targets, but these animal models exhibit biological and physiological differences when compared to humans. Thus to solve these discrepancies between animal models and human biology, human in vitro 3D lung tissue culture (3D-LTC) systems are developed and used in numerous areas of biomedical research. These 3D lung culture systems allows analysis of the spatial and functional relationships of cells in entire alveoli & airways, interstitium, vasculature and mesothelium. Remarkably, the in vitro models are multicellular, that is they comprise almost all the functional cells of in situ lungs, thus mimicking the native biological environment. Thus, researchers are now adopting lung model systems for in vitro studies. For instance, in April 2019 a report published in BioMed Central Ltd, used 3D lung microtissues for assessing nanomaterial-induced cell-matrix alterations and delineation of toxicity pathways. Similarly in 2018, School of Chemical Engineering, Oklahoma State University conducted a research project on a three-dimensional human tissue-engineered lung model to study influenza an infection.
Thus, the increasing adoption of model systems for in vitro studies is likely to enhance market growth during the forecast period.
Type -Based Insights
In terms of type, the global in vitro lung model market is segmented into 2D and 3D. In 2018, the 3D segment held largest share of the market. Moreover, the same segment is estimated to register the highest CAGR during the forecast period.
Global In Vitro Lung Model Market, by Type – 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
In terms of application, the global in vitro lung model market is segmented into drug screening, toxicology, 3D model development, stem cell research, physiologic research and regenerative medicine. In 2018, the toxicology segment held largest share of the market. The same segment is expected to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
In Vitro Lung Model Market: Strategic Insights
Market Size Value in US$ 185.80 Million in 2018 Market Size Value by US$ 701.81 Million by 2027 Growth rate CAGR of 16.2% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
In Vitro Lung Model Market: Strategic Insights
| Market Size Value in | US$ 185.80 Million in 2018 |
| Market Size Value by | US$ 701.81 Million by 2027 |
| Growth rate | CAGR of 16.2% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The global in vitro lung model market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global In Vitro Lung Model Market – by Type
- 2D
- 3D
Global In Vitro Lung Model Market – by Application
- Drug Screening
- Toxicology
- 3D Model Development
- Physiologic Research
- Stem Cell Research
- Regenerative Medicine
Global In Vitro Lung Model Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Epithelix Sàrl
- MATTEK
- LONZA
- InSphero
- Emulate, Inc.
- AlveoliX AG
- Thermo Fisher Scientific Inc
- PromoCell GmbH
- Merck KGaA
- Horizon Discovery Group plc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; Application and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global In Vitro Lung Model Market – By Type
1.3.2 Global In Vitro Lung Model Market – By Application
1.3.3 Global In Vitro Lung Model Market – By Geography
2. In Vitro Lung Model Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. In Vitro Lung Model– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 In Vitro Lung Model Market in North America: PEST Analysis
4.2.2 In Vitro Lung Model Market in Europe: PEST Analysis
4.2.3 In Vitro Lung Model Market in APAC: PEST Analysis
4.2.4 In Vitro Lung Model Market in MEA: PEST Analysis
4.2.5 In Vitro Lung Model Market – South and Central America PEST Analysis
4.3 Expert Opinion
5. Global In Vitro Lung Model Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Significant Growth in Research Funding
5.1.2 Increasing Adoption Of 3D Model Systems For In Vitro Studies
5.2 Key Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Key Market Opportunity
5.3.1 Rising Research on Lung Diseases
5.4 Future Trend
5.4.1 Increasing Number of Start Up Companies
5.5 Impact Analysis
6. In Vitro Lung Model Market – Global Analysis
6.1 Global In Vitro Lung Model Market Revenue Forecasts And Analysis
6.2 Global In Vitro Lung Model Market, By Geography - Forecasts And Analysis
6.3 Positioning Of Key Players
7. In Vitro Lung Model Market Analysis And Forecasts To 2027 – Type
7.1 Overview
7.2 Global In Vitro Lung Model Market, By Type 2018 & 2027 (%)
7.3 2D Market
7.3.1 Overview
7.3.2 Global 2D Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 3D Market
7.4.1 Overview
7.4.2 Global 3D Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 In House Market
7.4.3.1 Overview
7.4.3.2 Global In House Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Commercial Market
7.4.4.1 Overview
7.4.4.2 Global Commercial Market Revenue and Forecasts to 2027 (US$ Mn)
8. In Vitro Lung Model Market Analysis And Forecasts To 2027 – Application
8.1 Overview
8.2 Global In Vitro Lung Model Market, By Application 2018 & 2027 (%)
8.3 Drug Screening Market
8.3.1 Overview
8.3.2 Drug Screening Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Toxicology Market
8.4.1 Overview
8.4.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 3D Model Development Market
8.5.1 Overview
8.5.2 Global 3D Model Development Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Physiological Research Market
8.6.1 Overview
8.6.2 Global Physiological Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Stem Cell Research Market
8.7.1 Overview
8.7.2 Global Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Regenerative Medicine Market
8.8.1 Overview
8.8.2 Global Regenerative Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
9. In Vitro Lung Model Market Revenue And Forecasts To 2027 – Geographical Analysis
9.1 North America In Vitro Lung Model Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3.1 North America 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.4 North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.5 North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.1.6 US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 US In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.2.1 US 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 US In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.7 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.1 Canada 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Canada In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.1.8 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2.1 Mexico 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2 Europe In vitro lung model Market Revenue and Forecasts To 2027
9.2.1 Overview
9.2.2 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2.1 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.2.1.1 Europe 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.2.2 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.3 Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.2.4 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.4.1 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.4.2 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4.2.1 Germany 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4.3 Germany In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.5 UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.1 UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.5.2 UK In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.5.2.1 UK 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.5.3 UK In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.6 France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 France In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.6.2.1 France 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.6.3 France In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.7 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.2.1 Spain 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.3 Spain In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.2.8 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.8.2.1 Italy 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.8.3 Italy In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027
9.3.1 Overview
9.3.2 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.3.1 Asia Pacific 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.4 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.5 Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.3.6 China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.1 China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 China In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.6.2.1 China 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.6.3 China In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.7 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.2 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.7.2.1 Japan 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.7.3 Japan In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.8 India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.1 India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.2 India In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.8.2.1 India 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.8.3 India In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.9 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.2 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.9.2.1 South Korea 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.9.3 South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3.10 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.1 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.2 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.10.2.1 Australia 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.10.3 Australia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027
9.4.1 Overview
9.4.2 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.3 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.3.1 Middle East & Africa 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.4 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4.5 Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
9.4.6 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.2 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.6.2.1 South Africa 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.6.3 South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4.7 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.1 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.2 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.7.2.1 Saudi Arabia 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.7.3 Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.4.8 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.1 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.2 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.2.1 UAE 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.3 UAE In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.5 South and Central America In Vitro Lung Model Market Revenue and Forecast To 2027
9.5.1 Overview
9.5.2 South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
9.5.3 South and Central America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.3.1 South and Central America 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.4 South and Central America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.5.5 South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027, By Country (%)
9.5.6 Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.1 Argentina In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
9.5.6.2 Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.6.2.1 Argentina 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.6.3 Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.5.7 Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
9.5.7.2 Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.7.2.1 Brazil 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.7.3 Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)
10. In Vitro Lung Model Market– Industry Landscape
10.1 Overview
10.2 Growth Strategies in the In Vitro Lung Model Market, 2016-2019
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.1.1 Recent Organic Developments By Players In The In vitro lung model Market
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.1.1 Recent Inorganic Developments By Players In The In Vitro lung model Market
11. In Vitro Lung Model Market–Key Company Profiles
11.1 Epithelix Sàrl
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 MATTEK
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 LONZA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 InSphero
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Emulate, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 AlveoliX AG
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PromoCell GmbH
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Merck KgaA
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Horizon Discovery Group plc
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product/ Services Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by major Biotechnology companies
Table 2. North America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 3. North America 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 4. North America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 5. US In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 6. US 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 7. US In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 8. Canada In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 9. Canada 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 10. Canada In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 11. Mexico In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 12. Mexico 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 13. Mexico In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 14. Europe In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 15. Europe 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 16. Europe In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 17. Germany In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 18. Germany 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 19. Germany In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 20. UK In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 21. UK 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 22. UK In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 23. France In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 24. France 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 25. France In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 26. Spain In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 27. Spain 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 28. Spain In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 29. Italy In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 30. Italy 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 31. Italy In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 32. Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 33. Asia Pacific 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 34. Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 35. China In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 36. China 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 37. China In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 38. Japan In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 39. Japan 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 40. Japan In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 41. India In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 42. India 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 43. India In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 44. South Korea In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 45. South Korea 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 46. South Korea In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 47. Australia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 48. Australia 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 49. Australia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 50. Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 51. Middle East & Africa 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 52. Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 53. South Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 54. South Africa 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 55. South Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 56. Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 57. Saudi Arabia 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 58. Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 59. UAE In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 60. UAE 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 61. UAE In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 62. South and Central America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 63. South and Central America 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 64. South and Central America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 65. Argentina In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 66. Argentina 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 67. Argentina In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 68. Brazil In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 69. Brazil 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 70. Brazil In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 71. Recent Organic Developments in the In vitro lung model Market
Table 72. Recent Inorganic Developments By Players In The In Vitro lung model Market
Table 73. Glossary of Terms, in vitro lung model Market
LIST OF FIGURES
Figure 1. In vitro lung model Market Segmentation
Figure 2. In vitro lung model Segmentation, By Region
Figure 3. Global In Vitro Lung Model Market Overview
Figure 4. 3D Segment Held Largest Share Of Type Segment In In Vitro Lung Model Market
Figure 5. North America Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global In Vitro Lung Model Market, By Geography (US$ Mn)
Figure 7. Global In Vitro Lung Model Market- Leading Country Markets (US$ Mn)
Figure 8. Global In Vitro Lung Model Market, Industry Landscape
Figure 9. In Vitro Lung Model Market in North America: PEST Analysis
Figure 10. In Vitro Lung Model Market in Europe: PEST Analysis
Figure 11. In Vitro Lung Model Market in APAC: PEST Analysis
Figure 12. In Vitro Lung Model Market MEA: PEST Analysis
Figure 13. In Vitro Lung Model Market – South And Central America PEST Analysis
Figure 14. Global In Vitro Lung Model Market Impact Analysis Of Driver and Restraints
Figure 15. Global In Vitro Lung Model Market – Revenue Forecasts And Analysis – 2018- 2027
Figure 16. Global In Vitro Lung Model Market – By Geography Forecasts And Analysis – 2018- 2027
Figure 17. Market Positioning Of Key Player In Global In Vitro Lung Model Market
Figure 18. Global In Vitro Lung Model Market, by Type 2018 & 2027 (%)
Figure 19. Global 2D Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global 3D Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global in house Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Commercial Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global In Vitro Lung Model Market, by Application 2018 & 2027 (%)
Figure 24. Global Drug Screening Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global 3D Model Development Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Global Physiological Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Regenerative Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America In Vitro Lung Model Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 31. North America In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
Figure 33. US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 35. Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Europe In vitro lung model Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 37. Europe In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
Figure 39. Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Asia Pacific In Vitro Lung Model Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 45. Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
Figure 47. China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. Middle East & Africa In Vitro Lung Model Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 53. Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)
Figure 55. South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 56. Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. South and Central America In Vitro Lung Model Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 59. South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
Figure 60. South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027, By Country (%)
Figure 61. Argentina In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
Figure 62. Brazil In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)
Figure 63. Growth Strategies in the In Vitro Lung Model Market, 2016-2019
The List of Companies
- Epithelix Sàrl
- MATTEK
- LONZA
- InSphero
- Emulate, Inc.
- AlveoliX AG
- Thermo Fisher Scientific Inc
- PromoCell GmbH
- Merck KGaA
- Horizon Discovery Group plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to In Vitro Lung Model Market
Nov 2019
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2019
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2019
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2019
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2019
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2019
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2019
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2019
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)